Cargando…
Fibroblast Growth Factor Signaling in Metabolic Regulation
The prevalence of obesity is a growing health problem. Obesity is strongly associated with several comorbidities, such as non-alcoholic fatty liver disease, certain cancers, insulin resistance, and type 2 diabetes, which all reduce life expectancy and life quality. Several drugs have been put forwar...
Autores principales: | Nies, Vera J. M., Sancar, Gencer, Liu, Weilin, van Zutphen, Tim, Struik, Dicky, Yu, Ruth T., Atkins, Annette R., Evans, Ronald M., Jonker, Johan W., Downes, Michael Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718082/ https://www.ncbi.nlm.nih.gov/pubmed/26834701 http://dx.doi.org/10.3389/fendo.2015.00193 |
Ejemplares similares
-
Autocrine FGF1 signaling promotes glucose uptake in adipocytes
por: Nies, Vera J. M., et al.
Publicado: (2022) -
Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application
por: Struik, Dicky, et al.
Publicado: (2019) -
Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
por: Aaldijk, Alexandra S., et al.
Publicado: (2023) -
Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023) -
Fibroblast Growth Factor 21 Analogs for Treating Metabolic Disorders
por: Zhang, Jun, et al.
Publicado: (2015)